| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5832156 | International Immunopharmacology | 2015 | 10 Pages |
Abstract
Our results indicated that laquinimod treatment ameliorates colitis in Il10â/â mice and improves intestinal barrier function, which may support a new therapeutic approach to Crohn's disease.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jing Sun, Xiao Shen, Jianning Dong, Jie Zhao, Lugen Zuo, Honggang Wang, Yi Li, Weiming Zhu, Jianfeng Gong, Jieshou Li,